Company intelligence / Profile preview

ELEM Biotech

Barcelona, Catalonia, Spainelem.bio ↗

Ownership: Private
Employees: ~48
Development stage: Commercial

Overview

ELEM Biotech has developed a cloud-deployed supercomputing platform that creates virtual human populations for in silico clinical trials. Their technology enables the simulation of patient-specific responses to drugs and medical devices. This approach reduces reliance on animal/human testing and accelerates evidence generation for regulatory approval. No direct clinical trial results are reported since the company provides enabling technology rather than therapeutics.

Therapeutic areas: CardiovascularInfectious Diseases
Modalities: DeviceSmall moleculeDigital health platform
Industry: Drug Discovery Services

Partnerships

Oracle Cloud Infrastructure (cloud computing partner)Viridien Group (HPC cloud infrastructure partner)

Beyond the preview

Go deeper on ELEM Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ELEM Biotech.

Explore the full profile